DTL
AXSM icon

Dynamic Technology Lab’s Axsome Therapeutics AXSM Stock Holding History

Dynamic Technology Lab’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,040
Closed -$283K – 1040
2023
Q3 		$283K Buy
+4,040
New +$302K 0.03% 685
2023
Q1 		– Sell
-5,802
Closed -$448K – 1084
2022
Q4 		$448K Sell
5,802
-3,408
-37% -$204K 0.04% 619
2022
Q3 		$411K Buy
+9,210
New +$460K 0.04% 700
2022
Q1 		– Sell
-5,382
Closed -$204K – 1097
2021
Q4 		$204K Buy
+5,382
New +$198K 0.02% 955
2021
Q2 		– Sell
-5,626
Closed -$319K – 1129
2021
Q1 		$319K Buy
+5,626
New +$396K 0.04% 776
2020
Q3 		– Sell
-4,999
Closed -$411K – 996
2020
Q2 		$411K Buy
+4,999
New +$385K 0.06% 526
2020
Q1 		– Sell
-2,728
Closed -$282K – 1025
2019
Q4 		$282K Sell
2,728
-20,778
-88% -$839K 0.05% 700
2019
Q3 		$476K Buy
+23,506
New +$604K 0.08% 450
2018
Q2 		– Sell
-26,478
Closed -$65K – 985
2018
Q1 		$65K Buy
+26,478
New +$79.3K 0.01% 986

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dynamic Technology Lab's AXSM Position: Q4 2023 in Review

Dynamic Technology Lab sold out of Axsome Therapeutics (AXSM) in Q4 2023, closing a stake of 4,040 shares — an estimated $283K sold.

Dynamic Technology Lab first reported a position in AXSM in Q1 2018 and held it in 9 quarters. The position peaked at $476K in Q3 2019. 244 funds tracked by Wall St. Rank hold AXSM as of Q4 2023.

  • Dynamic Technology Lab reported no remaining Axsome Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 4,040 Axsome Therapeutics shares in Q4 2023, an estimated $283K.
  • Dynamic Technology Lab first reported a position in Axsome Therapeutics in Q1 2018 and held it in 9 quarters.
  • Dynamic Technology Lab's Axsome Therapeutics position peaked at $476K in Q3 2019.
  • 244 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.